Prognostic Discrepancy on Overall Survival Between Ambulatory and Nonambulatory Patients with Metastatic Spinal Cord Compression

• Published in: World neurosurgery Vol. 121; pp. e322 - e332
• Main Authors: Feng, Jiang-tao, Yang, Xiong-gang, Wang, Feng, Hua, Kun-chi, Liu, Yong-heng, Hu, Yong-cheng, Zhang, Hao, Yang, Li, Xu, Ming-you, Zhang, Hao-ran
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2019
• Subjects: Ambulatory status; Metastatic spinal cord compression; Overall survival; Prognostic factor; MSCC; NSCLC; OS; Ambulatory status; Prognostic factor; Metastatic spinal cord compression; Overall survival; KPS
• DOI: 10.1016/j.wneu.2018.09.102
• ISSN: 1878-8750

Contradictory results have been reported regarding the prognostic effect of ambulatory status in patients with metastatic spinal cord compression (MSCC). The aim of this study was to investigate whether ambulatory status is a significant predictor of overall survival in patients with MSCC and to distinguish the differences of predictors between patients who were ambulatory and those who were not ambulatory before operation. Three clinical centers were retrospectively reviewed to identify patients operated on for MSCC between 2005 and 2015. Fourteen prognostic factors were analyzed using Kaplan-Meier survival curves, univariate log-rank test, and multivariate Cox hazard regression model for the whole cohort and the subgroups of ambulatory and nonambulatory patients. In all, 169 patients were consecutively enrolled. Their mean age was 59.6 ± 10.5 years (range, 18–84 years). The median survival time in the whole cohort was 7.0 ± 0.5 months, whereas it was 7.0 ± 0.8 months and 5.0 ± 1.3 months in ambulatory and nonambulatory patients, respectively. Multivariate Cox regression analysis showed that ambulatory status was not a significant predictor of overall survival (P = 0.266), but primary tumor type and Karnofsky performance status were independent predictors of overall survival for the whole cohort. Primary tumor and metastatic site were significantly associated with survival in ambulatory patients. Gender and Karnofsky performance status were associated with survival in nonambulatory patients. Ambulatory status was not shown to predict the prognosis of patients with MSCC. prognostic factors should be distinguished between ambulatory and nonambulatory patients when choosing a therapeutic modality. •Ambulatory status was unpredictable for prognosis of patients with MSCC.•Primary tumor and spinal metastasis location are predictable for ambulatory patients.•While gender and KPS are significant predictors in non-ambulatory patients.